Immatics NV (IMTX)
7.43
+0.06
(+0.81%)
USD |
NASDAQ |
Oct 09, 16:00
7.42
-0.01
(-0.13%)
After-Hours: 20:00
Immatics Cash from Operations (Quarterly) : -70.00M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -70.00M |
| March 31, 2026 | -49.19M |
| December 31, 2025 | -67.73M |
| September 30, 2025 | -54.81M |
| June 30, 2025 | -47.04M |
| March 31, 2025 | -36.00M |
| December 31, 2024 | -59.20M |
| September 30, 2024 | -38.50M |
| June 30, 2024 | -35.48M |
| March 31, 2024 | -35.39M |
| December 31, 2023 | 85.80M |
| September 30, 2023 | -33.19M |
| June 30, 2023 | -7.557M |
| March 31, 2023 | -25.44M |
| December 31, 2022 |
| Date | Value |
|---|---|
| September 30, 2022 | |
| June 30, 2022 | 51.85M |
| March 31, 2022 | 122.39M |
| December 31, 2021 | -28.45M |
| September 30, 2021 | -20.90M |
| June 30, 2021 | -24.03M |
| March 31, 2021 | -20.06M |
| December 31, 2020 | -32.09M |
| September 30, 2020 | -57.03M |
| June 30, 2020 | 18.26M |
| March 31, 2020 | -31.16M |
| December 31, 2019 | 28.23M |
| September 30, 2019 | 52.68M |
| June 30, 2019 | -5.293M |
| March 31, 2019 | -0.2816M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| BioNTech SE | 12.56M |
| MediGene AG | -- |
| InflaRx NV | -2.937M |
| Twist Bioscience Corp. | 1.115M |
| Prime Medicine, Inc. | -41.05M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -9.277M |
| Cash from Financing (Quarterly) | -0.9257M |
| Free Cash Flow | -246.23M |
| Free Cash Flow Per Share (Quarterly) | -0.5195 |
| Free Cash Flow to Equity (Quarterly) | -70.32M |
| Free Cash Flow to Firm (Quarterly) | -70.77M |
| Free Cash Flow Yield | -25.54% |